Update: 12.11.2024
Last week: 44 week 2024 (28.10.2024 - 03.11.2024)
Last full month: October 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 10 036 | -5.5% | 13.0% | -0.2 | 17 444 181 | -5.5% | 8.6% | -0.2 | -3.8% |
| MoM | 46 299 | 25.2% | 13.5% | 0.1 | 78 544 747 | 16.9% | 8.8% | -0.4 | 24.4% |
| YTD | 343 036 | 23.3% | 12.1% | 3.2 | 694 885 109 | 32.1% | 9.3% | 1.8 | -9.1% |
| MAT | 405 588 | 23.6% | 11.8% | 2.9 | 825 618 756 | 34.1% | 9.2% | 1.7 | -6.4% |
| BRAINMAX | |||||||||
| WoW | 2 759 | 5.2% | 100.0% | 0 | 9 623 243 | 8.7% | 100.0% | 0 | 5.2% |
| MoM | 11 465 | 51.5% | 100.0% | 0 | 38 983 593 | 47.0% | 100.0% | 0 | 51.5% |
| YTD | 62 348 | 70.3% | 100.0% | 0 | 218 388 233 | 74.5% | 100.0% | 0 | 70.3% |
| MAT | 72 396 | 74.2% | 100.0% | 0 | 254 244 414 | 80.6% | 100.0% | 0 | 74.2% |
| GOLDLINE PLUS | |||||||||
| WoW | 14 151 | -6.4% | 46.3% | -0.3 | 44 871 733 | -4.0% | 38.5% | 0.6 | -5.7% |
| MoM | 65 432 | 6.8% | 46.1% | 0.2 | 202 749 324 | 6.6% | 37.8% | 0.1 | 6.4% |
| YTD | 715 505 | -5.0% | 45.2% | 0.4 | 2 246 487 556 | -3.2% | 37.0% | -2.8 | -5.8% |
| MAT | 831 534 | -3.1% | 45.3% | 0.5 | 2 617 717 878 | -0.3% | 37.3% | -2.6 | -4.1% |
| MIGRENIUM | |||||||||
| WoW | 9 520 | 3.5% | 0.4% | 0 | 3 284 938 | 5.1% | 0.6% | 0.1 | -7.1% |
| MoM | 40 982 | -0.4% | 0.4% | 0 | 13 954 118 | 0.8% | 0.5% | 0 | 3.5% |
| YTD | 495 927 | -11.1% | 0.5% | -0.1 | 156 831 223 | 50.9% | 0.7% | 0.2 | 6.2% |
| MAT | 579 439 | -12.6% | 0.5% | -0.1 | 175 574 116 | 43.1% | 0.6% | 0.1 | 8.5% |
| MODELAX-N | |||||||||
| WoW | 27 950 | 1.0% | 20.7% | 0.8 | 13 709 687 | 4.2% | 13.9% | 0.8 | -3.0% |
| MoM | 119 788 | 11.4% | 20.1% | -0.5 | 57 090 549 | 12.1% | 13.2% | -0.3 | 13.9% |
| YTD | 1 245 482 | 27.7% | 22.2% | 3.3 | 549 860 558 | 76.0% | 14.3% | 3.9 | 8.5% |
| MAT | 1 438 304 | 31.7% | 21.4% | 3.3 | 620 289 581 | 76.2% | 13.6% | 3.5 | 11.1% |
| REDUXIN | |||||||||
| WoW | 9 804 | -5.8% | 32.1% | 0 | 50 858 798 | -5.9% | 43.6% | -0.2 | -5.7% |
| MoM | 46 001 | 7.6% | 32.4% | 0.4 | 237 476 007 | 7.9% | 44.3% | 0.6 | 6.4% |
| YTD | 519 158 | -7.1% | 32.8% | -0.4 | 2 754 433 977 | 11.5% | 45.3% | 3 | -5.8% |
| MAT | 598 333 | -5.8% | 32.6% | -0.6 | 3 156 483 505 | 13.8% | 45.0% | 2.9 | -4.1% |
| REDUXIN FORTE | |||||||||
| WoW | 3 104 | -1.1% | 10.2% | 0.5 | 12 961 760 | -5.9% | 11.1% | -0.1 | -5.7% |
| MoM | 13 965 | 1.4% | 9.8% | -0.5 | 59 017 541 | 0.1% | 11.0% | -0.7 | 6.4% |
| YTD | 144 208 | 1.3% | 9.1% | 0.6 | 620 694 730 | 12.3% | 10.2% | 0.7 | -5.8% |
| MAT | 167 881 | 3.5% | 9.1% | 0.7 | 721 361 196 | 14.8% | 10.3% | 0.7 | -4.1% |
| SALVISAR | |||||||||
| WoW | 15 087 | 4.3% | 2.0% | 0.2 | 6 638 600 | 4.1% | 1.8% | 0.2 | -6.4% |
| MoM | 58 452 | 22.5% | 1.7% | 0.2 | 25 561 706 | 25.4% | 1.5% | 0.2 | 8.1% |
| YTD | 458 650 | 7.6% | 1.4% | 0.1 | 190 200 327 | 35.8% | 1.3% | 0.2 | -2.7% |
| MAT | 530 820 | -1.2% | 1.3% | 0 | 213 895 139 | 19.7% | 1.2% | 0 | -0.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 343 036 | 23.3% | 12.1% | 3.2 | 694 885 109 | 32.1% | 9.3% | 1.8 | -9.1% |
| BRAINMAX | 62 348 | 70.3% | 100.0% | 0 | 218 388 233 | 74.5% | 100.0% | 0 | 70.3% |
| GOLDLINE PLUS | 715 505 | -5.0% | 45.2% | 0.4 | 2 246 487 556 | -3.2% | 37.0% | -2.8 | -5.8% |
| MIGRENIUM | 495 927 | -11.1% | 0.5% | -0.1 | 156 831 223 | 50.9% | 0.7% | 0.2 | 6.2% |
| MODELAX-N | 1 245 482 | 27.7% | 22.2% | 3.3 | 549 860 558 | 76.0% | 14.3% | 3.9 | 8.5% |
| REDUXIN CAPS | 519 158 | -7.1% | 32.8% | -0.4 | 2 754 433 977 | 11.5% | 45.3% | 3 | -5.8% |
| REDUXIN FORTE | 144 208 | 1.3% | 9.1% | 0.6 | 620 694 730 | 12.3% | 10.2% | 0.7 | -5.8% |
| SALVISAR | 458 650 | 7.6% | 1.4% | 0.1 | 190 200 327 | 35.8% | 1.3% | 0.2 | -2.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 405 588 | 23.6% | 11.8% | 2.9 | 825 618 756 | 34.1% | 9.2% | 1.7 | -6.4% |
| BRAINMAX | 72 396 | 74.2% | 100.0% | 0 | 254 244 414 | 80.6% | 100.0% | 0 | 74.2% |
| GOLDLINE PLUS | 831 534 | -3.1% | 45.3% | 0.5 | 2 617 717 878 | -0.3% | 37.3% | -2.6 | -4.1% |
| MIGRENIUM | 579 439 | -12.6% | 0.5% | -0.1 | 175 574 116 | 43.1% | 0.6% | 0.1 | 8.5% |
| MODELAX-N | 1 438 304 | 31.7% | 21.4% | 3.3 | 620 289 581 | 76.2% | 13.6% | 3.5 | 11.1% |
| REDUXIN CAPS | 598 333 | -5.8% | 32.6% | -0.6 | 3 156 483 505 | 13.8% | 45.0% | 2.9 | -4.1% |
| REDUXIN FORTE | 167 881 | 3.5% | 9.1% | 0.7 | 721 361 196 | 14.8% | 10.3% | 0.7 | -4.1% |
| SALVISAR | 530 820 | -1.2% | 1.3% | 0 | 213 895 139 | 19.7% | 1.2% | 0 | -0.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 10 036 | -5.5% | 13.0% | -0.2 | 17 444 181 | -5.5% | 8.6% | -0.2 | -3.8% |
| BRAINMAX | 2 759 | 5.2% | 100.0% | 0 | 9 623 243 | 8.7% | 100.0% | 0 | 5.2% |
| GOLDLINE PLUS | 14 151 | -6.4% | 46.3% | -0.3 | 44 871 733 | -4.0% | 38.5% | 0.6 | -5.7% |
| MIGRENIUM | 9 520 | 3.5% | 0.4% | 0 | 3 284 938 | 5.1% | 0.6% | 0.1 | -7.1% |
| MODELAX-N | 27 950 | 1.0% | 20.7% | 0.8 | 13 709 687 | 4.2% | 13.9% | 0.8 | -3.0% |
| REDUXIN CAPS | 9 804 | -5.8% | 32.1% | 0 | 50 858 798 | -5.9% | 43.6% | -0.2 | -5.7% |
| REDUXIN FORTE | 3 104 | -1.1% | 10.2% | 0.5 | 12 961 760 | -5.9% | 11.1% | -0.1 | -5.7% |
| SALVISAR | 15 087 | 4.3% | 2.0% | 0.2 | 6 638 600 | 4.1% | 1.8% | 0.2 | -6.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 46 299 | 25.2% | 13.5% | 0.1 | 78 544 747 | 16.9% | 8.8% | -0.4 | 24.4% |
| BRAINMAX | 11 465 | 51.5% | 100.0% | 0 | 38 983 593 | 47.0% | 100.0% | 0 | 51.5% |
| GOLDLINE PLUS | 65 432 | 6.8% | 46.1% | 0.2 | 202 749 324 | 6.6% | 37.8% | 0.1 | 6.4% |
| MIGRENIUM | 40 982 | -0.4% | 0.4% | 0 | 13 954 118 | 0.8% | 0.5% | 0 | 3.5% |
| MODELAX-N | 119 788 | 11.4% | 20.1% | -0.5 | 57 090 549 | 12.1% | 13.2% | -0.3 | 13.9% |
| REDUXIN CAPS | 46 001 | 7.6% | 32.4% | 0.4 | 237 476 007 | 7.9% | 44.3% | 0.6 | 6.4% |
| REDUXIN FORTE | 13 965 | 1.4% | 9.8% | -0.5 | 59 017 541 | 0.1% | 11.0% | -0.7 | 6.4% |
| SALVISAR | 58 452 | 22.5% | 1.7% | 0.2 | 25 561 706 | 25.4% | 1.5% | 0.2 | 8.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs